HM30181AK Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HM30181AK Tablet, covering 2010-09-13 to 2010-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet [Phase 1]